Biotechnology
Finding Value in a 'Unique' Niche of the Healthcare Sector
Insider buying by the new CEO of this buyer of biopharmaceutical royalties, puts this name on my radar.
These Small-Cap Biotech Stocks Have the Wind at Their Back
After getting a 'win' earlier this week on an acquisition, let's highlight a few similar names in my portfolio.
Legend Biotech's Story Is Still Playing Out
Let's check the charts after this biotech reports earnings and snags a new 'buy' recommendation.
Gilead Sciences Touches a Key Moving Average, So Is It Time to Buy?
It looks as though the answer could be yes as the shares of the biopharmaceutical company have built a nice base.
Why Are CRISPR Therapeutics Charts Saying 'Buy'?
Here's where traders could go long.
These 3 Global Drug Stocks Have a Prescription for High Yields
Let's review three pharma companies based outside the U.S. that promise reasonable valuations and solid dividend yields.
Take a Look Under the Microscope at These Two Biopharma Stocks
I've noticed that biotech has been one area of strength lately.
Novavax Rallies and More Gains May Lie Ahead
Here's where aggressive traders could go long.
3 Cash-Rich Biotechs in a Market That's Tough on the Debt Burdened
There are reasons besides their cash positions to think these companies could see their stocks improve going forward.
This Biotech Is a Sight for Sore Eyes
Let's see how to play Aldeyra Therapeutics, a promising small-cap company out of Massachusetts.